TABLE 1. Comparing and contrasting measles and rubella characteristics relevant to elimination.
Characteristic |
Measles |
Rubella |
---|---|---|
Infectivity |
One of the most infectious viruses of humans |
Variable according to population size, but moderate |
Basic reproduction number (R0) |
12–18 (10) |
Median 5.2 (11) |
Population immunity levels required to interrupt transmission |
93% |
Around 80% |
Vaccine effectiveness (VE) of single dose |
Depends strongly on age at first dose: 9 months 85% 12 months 93% |
95% |
VE of 2 doses |
If MCV1 at 12 months, 97% |
>95% |
Coverage required to interrupt transmission |
>95% two dose |
Around 80% single dose |
Waning immunity over time |
None following infection, slow following two doses given at 12 months and older, potentially more rapid when MCV1 given earlier than 12 months |
None observed |
Requirements to elimination |
Cannot eliminate with a single dose |
Can eliminate with a single dose |
Highest risk age group |
Infants at highest risk of severe outcomes, followed by adults. Pregnant women are at higher risk of severe outcomes. |
Developing fetus in first trimester |
Critical community size to sustain transmission |
250–400 000 (12) |
1 million (13) |
Strategy |
Immunization programs aim to protect infants, boys and girls, through herd immunity. Direct protection of infants via early doses from 6 months is offered in high-risk settings. |
Women of childbearing age are protected through herd immunity in countries where adult immunization campaigns have not been implemented. Some countries have adult catch-up strategies but women-only not recommended. |
MCV1: measles-containing vaccine, first dose.
Source: Prepared by the authors.